Valentine Capital Asset Management’s Gilead Sciences GILD Stock Holding History

Valentine Capital Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$1M	Sell	9,900 -1,800	-15%	-$187K	1.12%	39
2015 Q3	$1.15M	Sell	11,700 -3,800	-25%	-$422K	1.02%	39
2015 Q2	$1.81M	Sell	15,500 -14,800	-49%	-$1.62M	1.22%	34
2015 Q1	$2.97M	Buy	+30,300	New	+$3.08M	0.87%	52
2014 Q4	–	Sell	-3,000	Closed	-$319K	–	102
2014 Q3	$319K	Hold	3,000	–	–	0.12%	57
2014 Q2	$249K	Hold	3,000	–	–	0.05%	109
2014 Q1	$213K	Hold	3,000	–	–	0.04%	121
2013 Q4	$225K	Buy	+3,000	New	+$209K	0.05%	116

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Valentine Capital Asset Management's GILD Position: Q4 2015 in Review

Valentine Capital Asset Management reduced its Gilead Sciences (GILD) stake by 15% in Q4 2015, selling an estimated $187K and leaving 9,900 shares worth $1M. The position accounts for 1.12% of the portfolio, ranked #39.

Valentine Capital Asset Management first reported a position in GILD in Q4 2013 and has held it in 8 quarters since. The position peaked at $2.97M in Q1 2015. 1,628 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

Valentine Capital Asset Management held 9,900 shares of Gilead Sciences worth $1M as of Q4 2015.
Valentine Capital Asset Management sold 1,800 Gilead Sciences shares in Q4 2015, an estimated $187K.
Gilead Sciences made up 1.12% of Valentine Capital Asset Management's portfolio in Q4 2015, its #39 holding.
Valentine Capital Asset Management first reported a position in Gilead Sciences in Q4 2013 and has held it in 8 quarters since.
Valentine Capital Asset Management's Gilead Sciences position peaked at $2.97M in Q1 2015.
1,628 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Valentine Capital Asset Management's 13F filing for Q4 2015, filed 17 Feb 2016.